Foundation for innovation
in Cardiometabolism and Nutrition

IHU-ICAN

Communication

TRaining

clinical TEams

Cardiometabolism

INnovative care Pathways

Reference Centers

Research Teams

research

research focus Area

Our Support

clinical Investigation

scientific Plateforms

Parterships

Why Support ICAN?

How to support ICAN?

projects to Support

Research

  • ICAN IHU Renewal: Discover Our 2026–2030 Scientific Strategy

    ICAN IHU Renewal: Discover Our 2026–2030 Scientific Strategy

    ,
    Read More
  • Neuder Law: France Adopts a National Strategy for the Prevention of Cardiovascular and Neurological Diseases

    Neuder Law: France Adopts a National Strategy for the Prevention of Cardiovascular and Neurological Diseases

    ,
    Read More
  • The Cardiometabolic Continuum: 10 Major Scientific Publications That Advance Research

    The Cardiometabolic Continuum: 10 Major Scientific Publications That Advance Research

    Read More
  • A major breakthrough in understanding the mechanisms of atrial cardiomyopathy

    A major breakthrough in understanding the mechanisms of atrial cardiomyopathy

    Read More
  • IHU ICAN’s 2026 Scientific Conference: Discover the Award Winners’ Research Projects!

    IHU ICAN’s 2026 Scientific Conference: Discover the Award Winners’ Research Projects!

    ,
    Read More
  • General practitioners: Help with the early screening of patients at risk for metabolic fatty liver disease (GRIPonMASH project)

    General practitioners: Help with the early screening of patients at risk for metabolic fatty liver disease (GRIPonMASH project)

    ,
    Read More
  • Cardiovascular-kidney-metabolic (CKM): Toward a more integrated approach to cardiometabolic diseases

    Cardiovascular-kidney-metabolic (CKM): Toward a more integrated approach to cardiometabolic diseases

    Read More
  • ANNITIA Data Challenge: Using AI to Better Predict the Progression of Non-Alcoholic Fatty Liver Disease

    ANNITIA Data Challenge: Using AI to Better Predict the Progression of Non-Alcoholic Fatty Liver Disease

    ,
    Read More
  • The women driving cardiometabolic research forward at the IHU ICAN

    The women driving cardiometabolic research forward at the IHU ICAN

    Read More
  • Discovery of a new biomarker for non-invasive diagnosis of MASH: thrombospondin-2 

    Discovery of a new biomarker for non-invasive diagnosis of MASH: thrombospondin-2 

    Read More

Stay in touch

Get all the latest news from the ICAN Foundation

This field is for validation purposes and should be left unchanged.
Privacy Policy(Required)
Tracking pixel

OUr founders

ISO 9001 Certified

OUr Institutionnal Supporters

Our network